Sanofi/ FR0000120578 /
2024-12-23 3:59:17 PM | Chg. -0.4040 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
94.3460USD | -0.43% | 339 Turnover: 10,472.4060 |
-Bid Size: - | -Ask Size: - | 119.56 bill.USD | - | - |
Assets
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 10,182 | 10,396 | 9,943 | 10,019 | 9,579 | ||||||
Intangible Assets | 15,395 | 14,543 | 12,026 | 10,879 | 13,080 | ||||||
Long-Term Investments | 4,826 | 2,575 | 2,725 | 2,820 | 3,364 | ||||||
Fixed Assets | 67,985 | 69,095 | 66,927 | 66,895 | 69,150 | ||||||
Inventories | 6,352 | 6,562 | 6,516 | 6,892 | 6,816 | ||||||
Accounts Receivable | 6,831 | 7,149 | 7,386 | 7,311 | 7,216 | ||||||
Cash and Cash Equivalents | 8,257 | 7,341 | 9,148 | 10,273 | 10,315 | ||||||
Current Assets | 23,912 | 23,427 | 24,928 | 26,687 | 26,352 | ||||||
Total Assets | 96,065 | 97,392 | 102,321 | 104,672 | 99,826 |
Liabilities
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 3,003 | 3,651 | 3,817 | 4,297 | 4,633 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 39,051 | 41,124 | 44,111 | 46,948 | 41,568 | ||||||
Share Capital | 2,649 | 2,639 | 2,611 | 2,584 | 2,508 | ||||||
Total Equity | 56,885 | 56,120 | 58,049 | 57,554 | 58,089 | ||||||
Minority Interests | 129 | 148 | 161 | 170 | 169 | ||||||
Total liabilities equity | 96,065 | 97,392 | 102,321 | 104,672 | 99,826 |
Income Statement
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 32,951 | 33,770 | 34,542 | 33,821 | 35,055 | ||||||
Depreciation (total) | 2,914 | 2,482 | 2,137 | 1,692 | 1,866 | ||||||
Operating Result | 5,106 | 6,143 | 5,624 | 6,534 | 5,803 | ||||||
Interest Income | -503 | -412 | -381 | -856 | -273 | ||||||
Income Before Taxes | 4,603 | 5,731 | 5,243 | 5,678 | 5,530 | ||||||
Income Taxes | 763 | 1,171 | 709 | 1,326 | 1,722 | ||||||
Minority Interests Profit | -158 | -119 | -101 | -91 | -121 | ||||||
Net Income | 3,717 | 4,390 | 4,287 | 4,709 | 8,434 |
Per Share
Cash Flow
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 6,954 | 7,690 | 8,920 | 7,838 | 7,379 | ||||||
Cash Flow from Investing Activities | -1,273 | -3,460 | -3,257 | -2,637 | -2,896 | ||||||
Cash Flow from Financing | -3,726 | -5,180 | -3,601 | -3,990 | -7,902 | ||||||
Decrease / Increase in Cash | 1,876 | -916 | 1,807 | 1,125 | 42 | ||||||
Employees | 112,128 | 113,496 | 115,631 | 106,859 | 106,566 |